Powder: -20°C for 3 years | In solvent: -80°C for 1 year
3-Deazaneplanocin A (DZNep) is an attractive epigenetic anticancer agent through the inhibition of the cellular enhancer of zeste homolog 2 (EZH2) protein.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
500 μg | 4-5 weeks | $ 243.00 | |
1 mg | 4-5 weeks | $ 438.00 | |
5 mg | 4-5 weeks | $ 1,200.00 | |
10 mg | 4-5 weeks | $ 1,730.00 |
Description | 3-Deazaneplanocin A (DZNep) is an attractive epigenetic anticancer agent through the inhibition of the cellular enhancer of zeste homolog 2 (EZH2) protein. |
In vitro | Continuous exposure for 14 days to tubercidin alone is highly toxic to both human CFU-GM and BFU-E. The IC50s of tubercidin are 3.4±1.7 and 3.7±0.2 nM for CFU-GM and BFU-E, respectively. Tubercidin also has a direct dose-dependent inhibitory effect on myeloid and erythroid human bone marrow progenitor cells in vitro[1]. |
Molecular Weight | 262.26 |
Formula | C12H14N4O3 |
CAS No. | 102052-95-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 75 mM
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
3-Deazaneplanocin A 102052-95-9 Chromatin/Epigenetic Histone Methyltransferase 3-Deazaneplanocin inhibit Inhibitor 3Deazaneplanocin A Orthopoxvirus 3 Deazaneplanocin A DZNep inhibitor